{"id":"W1971737397","doi":"10.1111/j.1582-4934.2009.00991.x","title":"Clinical outcomes in non‐small‐cell lung cancer patients with <i>EGFR</i> mutations: pooled analysis","year":2010,"lang":"en","type":"review","venue":"Journal of Cellular and Molecular Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Eisai; F. Hoffmann-La Roche; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Gefitinib; Erlotinib; Lung cancer; Oncology; Medicine; Internal medicine; Epidermal growth factor receptor; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01135289,0.001795938,0.006969041,0.00332775,0.0002262777,0.001663058,0.0007365187,0.0009235004,0.001326667],"category_scores_gemma":[0.01258132,0.0007948803,0.01982268,0.003772309,0.0002575672,0.0008565937,0.001153766,0.0005719995,0.0002488478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006829834,"about_ca_system_score_gemma":0.0005933515,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001991202,"about_ca_topic_score_gemma":0.003334553,"domain_scores_codex":[0.9907395,0.004026561,0.002367721,0.001591637,0.0009880967,0.0002864345],"domain_scores_gemma":[0.9901204,0.00445979,0.003031599,0.0007493393,0.001377356,0.0002615609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.02135455,0.00006555021,0.1538079,0.01034013,0.7975723,0.0001763899,0.000085338,0.002001782,0.001523246,0.00006149926,0.0006843542,0.012327],"study_design_scores_gemma":[0.002589081,0.002963695,0.2436126,0.000827084,0.7445415,0.0003639867,0.0001380303,0.001629576,0.0008515033,0.000219041,0.002181922,0.00008189464],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6820891,0.2966684,0.004937084,0.0002482107,0.0003056217,0.0007551373,0.0129307,0.0001132655,0.001952441],"genre_scores_gemma":[0.9760017,0.01566167,0.001165639,0.000161049,0.0001431665,0.0005183278,0.005997992,0.0000346988,0.0003158821],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01135289,"threshold_uncertainty_score":0.06004059,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01356794701440404,"score_gpt":0.368742977523374,"score_spread":0.3551750305089699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}